During the past decade, Carolina Musculoskeletal Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolina Musculoskeletal Institute" #1 collaborator was "Baylor University" with 1 trials as a collaborator, "Integrium" with 1 trials as a collaborator and "Pamlab, L.L.C." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Carolina Musculoskeletal Institute" are "Diabetic Foot Ulcer" (1 trials) and "Diabetic Peripheral Neuropathy" (1 trials). Many other conditions were trialed in "Carolina Musculoskeletal Institute" in a lesser frequency.

Most popular intervention types in "Carolina Musculoskeletal Institute" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.03% DSC127 topical gel" (1 trials) and "Metanx® (Oral L-methylfolate, Methylcobalamin and Pyridoxal 5'-phosphate)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolina Musculoskeletal Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Carolina Musculoskeletal Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Carolina Musculoskeletal Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Carolina Musculoskeletal Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".